07 Jan 2001

Tonsilgon® N (Tonsilgon® N Dragees) - Deutschland

Updated: 07 Jan 2001

Tonsilgon® N

Rezidivierende u. chronische Atemwegsinfekte, insbes. Tonsillitis.

Tonsilgon® N Description, Presentation and Dosage

Tonsilgon® N Description

Tonsilgon® N Drug Class Description

Kombinationen

Tonsilgon® N Drug Description

1 Drg. enth.: pulv. Drogen: Rad. Althaeae 8 mg, Flor. Chamomillae 6 mg, Herba Equiseti 10 mg, Fol. Juglandis 12 mg, Herba Millefolii 4 mg, Cort. Quercus 4 mg, Herba Taraxaci 4 mg. 0,4 g, Herba Millefolii 0,4 g, Cort. Quercus 0,2 g, Herba Taraxaci 0,4 g - Auszugsmittel: 59 Vol.-% Ethanol.

Tonsilgon® N Generic Name

Tonsilgon® N Dragees

Tonsilgon® N Presentation

Tonsilgon® N Presentation

Tonsilgon® N

Tonsilgon® N Manufacturer

Bionorica

Related Learning Zones

Cystic Fibrosis Knowledge Centre

Cystic Fibrosis Knowledge Centre

Cystic fibrosis (CF) is a genetic condition caused by a defect in the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel. The Cystic Fibrosis Knowledge Centre provides healthcare professionals with access to disease awareness information, emerging and established treatment options and current best practice based on recently updated guidelines by the European Cystic Fibrosis Society (ECFS). A resources section contains external links to upcoming medical conferences and patient support groups.

This resource is developed by EPG Health Media for epgonline.org, supported by an independent educational grant from Vertex.

Type 2 Diabetes Knowledge Centre and CME

Type 2 Diabetes Knowledge Centre and CME

The Type 2 Diabetes Learning Zone comprises the Type 2 Diabetes Mellitus Knowledge Centre containing current epidemiology statistics, current diagnosis criteria from WHO and ADA, treatment options and latest guidelines; a Therapy Focus area compiling material on emerging insulin/incretin treatment combinations; and two free CME activities, which are the EACCME-accredited ‘Role of Newer Therapies for Type 2 Diabetes in Combination with Insulin’ (worth 1 CME credit) and ‘Best Practice in Type 2 Diabetes: Update on Incretin Therapies in Combination with Insulin’. 

Tonsilgon® N Dosage

Tonsilgon® N Adult Dosage

Calciumcarbonat, Lactose 1H2O, Montanglycolwachs, Povidon, Schellack, Stearinsäure, Talkum, Farbstoffe: E 132, E 171.

Tonsilgon® N Child Dosage


Tonsilgon® N Tropfen
Zus.: 100 g enth.: 29 g eines alkohol.-wäßrigen Auszugs aus Rad. Althaeae 0,4 g, Flor. Chamomillae 0,3 g, Herba Equiseti 0,5 g, Fol. Juglandis

Tonsilgon® N Precautions, Reactions and Contraindications

Tonsilgon® N Special Precautions

Tonsilgon® N Adverse Reactions

Tonsilgon® N Adverse Reactions

Gr 2 .

Related Drugs - Ear, Nose and Throat

Back to top